Vancouver, BC, September 13, 2011--(T-Net)--Steven Jones, a Simon Fraser University molecular biology and biochemistry (MBB) professor and head of bioinformatics at the B.C. Cancer Agency's Genome Sciences Centre, has been named a fellow of the Royal Society of Canada.
Jones, recognized for his leading contributions to the field of genome informatics, has participated in numerous international genome projects. He has applied similar techniques to study human cancers providing insights into the process of oncogenesis and how cancer treatment can be personalized.
An SFU alumnus and Burnaby resident, Jones was part of an international team that earlier identified a molecular compound that could lead to an antiviral drug to combat swine and avian flus. Jones and colleagues also developed a quicker, more affordable way to sequence genomes that could help fight the mountain pine beetle and cancer.
In 2010 Jones received more than $400,000 in funding from the Canadian Cancer Society Research Institute for research involving the use of genetic sequencing techniques to generate the first-ever comprehensive description of the molecular changes found in thyroid cancer.
Last year he was also part of a trio of SFU molecular biology and biochemistry researchers (together with Rob Holt and Marco Marra) to receive LifeSciences B.C.'s Genome B.C. Award for excellence in science.
Public Affairs and Media Relations
Simon Fraser University
Room 2200 Strand Hall
Photo credit: SFU Public Affairs and Media Relations. Steven Jones, a professor in molecular biology and biochemistry, has been named a fellow of the Royal Society of Canada. Jones, also behind a revolution in genome sequencing, is now helping to invent personalized cancer therapy, starting with the tongue.